Cerebral White Matter Lesions in Patients with Crohn's Disease

Journal of Neuroimaging

Volumn 22, Issue 1, 2012, Pages 38-41

  Chen, Merry ^a   Lee, Grace ^a   Kwong, Lawrence N ^b   Lamont, Sharon ^a   Chaves, Claudia ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Crohn's disease; MRI of the brain; White matter abnormalities

Indexed keywords

ADALIMUMAB; INFLIXIMAB;

ADULT; AGE; ARTICLE; BRAIN DAMAGE; COMORBIDITY; CONTROLLED STUDY; CROHN DISEASE; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GENDER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIGRAINE; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY; WHITE MATTER LESION;

COMORBIDITY; CROHN DISEASE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MASSACHUSETTS; MIDDLE AGED; NERVE FIBERS, MYELINATED; NEUROMUSCULAR DISEASES; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84862929489     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2010.00538.x     Document Type: Article

References (17)

1. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine 1976;55:401-412.
2. Danzi JT. Extraintestinal manifestations of idiopathic inflammatory bowel disease. Arch Internal Med 1988;148:297-302.
3. Gendelman S, Present D, Janowitz HD. Neurological complications of inflammatory bowel disease [abstract]. Gastroenterology 1982;82:1065.
4. Elsebety AE, Bertorini TE. Neurological complications in Crohn's disease [abstract]. Ann Neurol 1991;30:271
5. Lossos A, River Y, Eliakim A, et al. Neurologic aspects of inflammatory bowel disease. Neurology 1995;45:416-421.
6. De Georgia M, Rose D. (2008). Stroke in patients who have inflammatory bowel disease. In: L.R. Caplan, ed. Uncommon causes of stroke, 2nd ed. Cambridge : Cambridge University Press, 381-386.
7. Fromont A, DeSeze J, Fleury MC, et al. Inflammatory demyelinating events following treatment with anti-tumor necrosis factor. Cytokine 2009 Feb;45(2):55-57.
8. Geissler A, Andus T, Roth M, et al. Focal white-matter lesions in brain of patients with inflammatory bowel disease. Lancet 1995;345:897-898.
9. Hans-Joachim Kretschmann Wolfgang Weinrich. Cranial neutoimaging and clinical neuroanatomy. Atlas of MR Imaging and Computed Tomography. 3rd ed. New York : Thieme Stuttgart, 2004.
10. Bryan RN, Manolio TA, Schertz LD, et al. A method for using MR to evaluate the effects of cardiovascular disease on the brain: the cardiovascular health study. AJNR 1994 Oct;15(9):1625-1633.
11. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997, 120:2059-2069.
12. Tintore M, Rovira A, Martinez MJ, et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR 2000;21:702-706.
13. Schmidt R, Fazekas F, Koch M, et al. Magnetic resonance imaging cerebral abnormalities and neuropsychological test performance in elderly hypertensive subjects. A case- control study. Arch Neurol 1995;52:905-910.
14. Pavase N, Canapicchi R, Nuti A, et al. White matter MRI hyperintensities in a hundred and twenty-nine consecutive migraine patients. Cephalalgia 1994 Oct;14(5):342-345.
15. Swartz RH, Kern RZ. Migraine is associated with magnetic resonance imaging white matter abnormalities. A Meta-analysis. Arch Neurol 2004;61:1366-1368.
16. Horikoshi T, Yagi S, Fukamachi A. Incidental high-intensity foci in white matter on T2-weighted magnetic resonance imaging: frequency and clinical significance in symptom-free adults. Neuroradiology 1993;35:151-155.
17. Meguro K, Yamaguchi T, Hishinuma T, et al. Periventricular hyperintensity on magnetic resonance imaging correlated with brain ageing and atrophy. Neuroradiology 1993;35:125-129.